Guide to BioTerminology 2nd edition - - BioPharm International

ADVERTISEMENT

Guide to BioTerminology 2nd edition

BioPharm International


FDAMA FDA Modernization Act; enacted in November 1997, this amends the FD&C Act to improve (facilitate) the regulation of food, drugs, devices, and biological products.

feedstock Also feed or feed stream; most often the raw broth containing particles to be removed that is placed into a laboratory or manufacturing appliance such as a centrifuge or chromatography column.

feed stream Also feed or feedstock; most often the solution fed into a reaction or separation/ purification process.

fermentation Large-scale cultivation of microorganisms or single-celled creatures for industrial purposes, such as to produce therapeutic molecules or specialty foods and beverages.

fermentor A large bioreactor used to grow bacteria or fungi in liquid culture.

fibrinogen A soluble glycoprotein cleaved by thrombin at the site of a wound to yield fibrin (the protein that makes up a blood clot).

fill-and-finish The part of a manufacturing process concerned with packaging a product in its final form.

filter Porous material through which a liquid or gas is passed so that particulates and impurities are held in suspension and removed from the feed stream. Some impurities may pass through.

filtrate The part of a mixture that passes through a filter, also called permeate.

filtration Separation of solid particles from a fluid by passing the mixture through a porous, fibrous, or granular substance.

FISH Fluorescence in situ hybridization; an analytical method in which specific sequences of DNA are labeled with fluorescent molecules, hybridized (amplified), and then detected with a fluorescence microscope.

floc A fluffy aggregate that resembles a woolly cloud.

flocculant A precipitate (floc), sometimes a flaky or fluffy aggregate that resembles a woolly cloud; the aggregation (flocculation) of initially separate cells that form flocs.

flux Usually, the rate of flow. A lower flux means slower flow, usually caused by clogging.

fMet N-formyl methionine, a variant of the amino acid methionine that many bacterial cells can produce. In mammals, fMet results in a strong adverse reaction by the body.

FMEA Failure modes evaluation and analysis. A method used to perform risk assessment and risk mitigation. A unit operation is analyzed, and all the potential modes by which it might fail are mapped out. Then a control strategy is defined to reduce the probability that a given mode of failure will occur. Used in the aerospace and other industries with much success. (See also HACCP)

folding A process in which a protein spontaneously forms into its correct, knotted tertiary structure that is held in place by chemical bonds and by attractive forces between atoms.

follow-on biologic Another term for biosimilar or biogeneric.

for-cause inspection An FDA facility inspection carried out because of specific information such as the results of a sample analysis, observations made during previous inspections, product recall or market withdrawal, consumer or employee complaint, adverse reaction report, or suspicion of fraud. Also, a similar inspection of a clinic or an IRB.

formal experimental design A structured, organized method for determining the relationship between factors affecting a process and the output of that process. Also known as design of experiments. [ICH Q8]

formamide A colorless, oily, hygroscopic liquid used to denature nucleic acids and as a solvent, softener, or chemical intermediate.

formulation The method and process of selecting the components of a mixture; the product of such a process; the form in which a drug is given to patients (tablets or injections, for example); developed in concert with a drug delivery system and tar-geting mechanism needed to get the active ingredient to its site of action.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here